Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidapenem Combined With Azacitidine and Mitoxantrone Liposome (CAM) Regimen for Relapsed/Refractory Intra-nodal Follicular Adjuvant T-cell Lymphoma
NCT05772728Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tucidinostat in follicular T-cell lymphoma (FTCL), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
follicular T-cell lymphoma (FTCL)
Beyond the preview
Go deeper on NCT05772728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05772728.